Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy

Ruhnau, K. ‐J., Meissner, H. P., Finn, J. ‐R., Reljanovic, M., Lobisch, M., Schütte, K., Nehrdich, D., Tritschler, H. J., Mehnert, H., Ziegler, D. · 1999 · Diabetic Medicine

Abstract

Summary: Aims To evaluate the efficacy and safety of short‐term oral treatment with the antioxidant thioctic acid (TA) on neuropathic symptoms and deficits in patients with Type 2 diabetes mellitus with symptomatic polyneuropathy. Methods Patients were randomly assigned to oral treatment with 600 mg of TA t.i.d. (n= 12) or placebo (n= 12) for 3 weeks. Neuropathic symptoms (pain, burning, paraesthesiae, and numbness) in the feet were scored at weekly intervals and summarized as a Total Symptom Score (TSS). The Hamburg Pain Adjective List (HPAL) and the Neuropathy Disability Score (NDS) were assessed at baseline and day 19. Results At baseline the TSS, HPAL, and NDS were not significantly different between the groups. The TSS in the foot decreased from baseline to day 19 by − 3.75 ± 1.88 points ( − 47%) in the TA group and by − 1.94 ± 1.50 points ( − 24%) in the placebo group (P= 0.021 for TA vs. placebo). The total HPAL score decreased from baseline to day 19 by − 2.20 ± 1.65 points ( − 60%) in the TA group and by − 0.96 ± 1.32 points ( − 29%) in the placebo group (P= 0.072 for TA vs. placebo). The NDS decreased by − 0.27 ± 0.47 points in the TA group, whereas it slightly increased by + 0.18 ± 0.4 points in the placebo group (P= 0.025 for TA vs. placebo). No differences between the groups were noted regarding the rates of adverse events. Conclusions These preliminary findings indicate that oral treatment with 600 mg of TA t.i.d. for 3 weeks may improve symptoms and deficits resulting from polyneuropathy in Type 2 diabetic patients, without causing significant adverse reactions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.1999.00190.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 178

Metadata

Authors
Ruhnau, K. ‐., Meissner, H. P., Finn, J. ‐., Reljanovic, M., Lobisch, M., Schütte, K., Nehrdich, D., Tritschler, H. J., Mehnert, H., & Ziegler, D.
Venue
Diabetic Medicine
Publisher
Wiley
Published
1999-12
Volume
16
Issue
12
Pages
1040-1043
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2129576263
Cited by
178
References
2
FWCI
3.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy. https://app.cochat.ai/papers/10.1046/j.1464-5491.1999.00190.x
The paper
Ruhnau, K. ‐., Meissner, H. P., Finn, J. ‐., Reljanovic, M., Lobisch, M., Schütte, K., Nehrdich, D., Tritschler, H. J., Mehnert, H., & Ziegler, D. (1999). Effects of 3‐week oral treatment with the antioxidant thioctic acid (α‐lipoic acid) in symptomatic diabetic polyneuropathy. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.1999.00190.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.